It is thus highly plausible that FOSL1 rearrangements operate through the same mechanism, i.e. reduced FOSL1 protein degradation, which is supported by our finding of intense FOSL1 protein immunoreactivity in mutant tumours. Here, FOSL1 is linked to neoplasm.